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open access article under the CC BY-NAbstract Introduction: Rapid Adenosine Triphosphate (ATP) testing is becoming a commonly
used method to measure cleanliness on reusable medical devices and healthcare environ-
mental surfaces. Unfortunately, ATP testing devices suffer from inherent variability from a
number of sources including imprecision in ATP measurement.
Method: This paper proposes a new sampling algorithm which reduces the impact of inherent
variability and thus improves decision making when using ATP testing.
Conclusion: This algorithm can be applied across a variety of applications to provide more reli-
able data on measurable cleanliness standards for both medical devices and environmental
surfaces. Formal trials using the new ATP sampling algorithm are required.
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Highlights
 ATP testing is subject to inherent variability that causes imprecision with ATP readings.
 The variability problems undermine data validity from ATP testing.
 This algorithm mitigates the ATP testing variability and improves the reliability of ATP
testing results.
 The algorithm can be applied across all brands of ATP testing devices.
 The algorithm improves the utility of ATP testing for all cleanliness monitoring applications.
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Table 1 Suggested cleanliness thresholds and corre-














TC3 25 RLU 125 RLU 115 RLU
Lower Limit of
Quantitation
LLQ 0 RLU 100 RLU 90 RLU
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The role of rapid ATP testing in cleanliness
measurements
Cleanliness testing using rapid Adenosine Triphosphate
(ATP) testing has been suggested as a quantitative method
of assessing surface hygiene that is superior to simple visual
inspection [1]. Rapid ATP testing devices are simple to use,
lightweight and portable, provide an almost immediate
reading and the consumables are relatively inexpensive.
Rapid ATP testing devices measure all cellular ATP and not
just microbial ATP, thus rapid ATP testing is a broad indi-
cator of cleanliness from all biological soils and useful for
cleanliness monitoring [2].
ATP testing is not a substitute for microbiological testing
of surfaces although a number of studies have indicated the
value of rapid ATP testing for cleanliness monitoring and
training within healthcare settings [3,4]. The measurement
of ATP contained in log scale dilution series of bacterial
cultures does correlates with the concentrations of bacte-
ria present and thus ATP testing provides an indication of
bacterial contamination [5e7].
Studies using ATP testing for cleanliness measurements
have compared various alternative methods for cleanliness
monitoring and shown that ATP testing is a more reliable
indicator [8]. Rapid ATP testing has also been used across a
range of hospital settings to investigate cleaning perfor-
mance standards [9]. ATP testing on a range of different
healthcare environmental surfaces also showed that ATP
was a sensitive method for setting cleanliness standards
based on ATP measurements [10].
Studies using ATP testing to monitor the cleanliness of
reusable medical devices such as endoscopes have also
been published [11e13]. Establishing suitable cleanliness
benchmarks using ATP testing has also been suggested
[12,14]. The use of rapid ATP testing for cleanliness moni-
toring of Gastro Endoscopes (GES) was also compared
favourably with monitoring of residual protein and micro-
bial contaminants noting that the detection limits for
differing methods were not always consistent or appropri-
ately scaled [15].
It has been noted that the use of ATP testing for clean-
liness monitoring within healthcare settings is a currently
developing area of science that requires further study [16].
However, questions have been posed over the reliability
of the results arising from ATP testing [17,18]. Recent na-
tional guidelines have chosen to not incorporate ATP testing
into cleanliness monitoring for healthcare environmental
surfaces [19].
Variability and imprecision with ATP testing
The first difficulty when using ATP testing devices in the
field, is that the surfaces being tested may not be uniformly
covered by human cells, bacterial cells or even food based
cellular materials. The variability of soil distribution on a
surface, whether bacterial or other ATP rich soils, is a
confounder for ATP testing even before device related is-
sues are considered. So, a low reading on one location may
not indicate a low reading across entire surface.This problem is not unique to ATP testing devices.
The sampling area for swabbing with ATP testing devices
is also not standardised. When ATP testing was first pro-
posed by Griffiths et al. the sampling area was a 10  10 cm
(100 cm2) area with a target level of cleanliness of 500
Relative Light Units (RLU) using a Cleantrace ATP testing
device [1]. Following studies using the same branded
equipment and same sampling area the cleanliness stan-
dard was reassessed and suggested as only 250 RLU [10].
More recently a study using a different brand of equipment
(Hygiena) has suggested that the cleanliness standard be
reduced to just 100 RLU using a 100 cm2 sampling area [20].
Finally, another study using the Hygiena ATP reaffirmed the
100 RLU cleanliness threshold, but reduced the sampling
area to a more practical 2  5 cm (10 cm2) area [21].
Another complication is that every ATP testing device
reads on a brand specific and arbitrary scale even though all
share the common name of Relative Light Units or RLU [22].
The results of comparison testing of different brands of ATP
testing devices has shown wide dissimilarities between the
RLU scaling at standardised testing levels with both pure
ATP and bacterial cultures [6,7].
An earlier study found that for some brands of ATP
testing devices (e.g. Cleantrace [3M], Kikkoman), the lower
level of detectability (LLD) is appreciably below the lower
level of quantitation (LLQ). In plain language that means
that those ATP devices can detect low levels ATP but
cannot precisely or reliably indicate the quantity of ATP
which is detected. At lower levels of ATP contamination,
the meter readings contain relatively higher levels of error.
Where an ATP testing reading is obtained which is
below the LLQ, then this data should be expressed as ‘less
than “n” RLU’ (where “n” Z the LLQ). For practical field
usage, it would be better if the LLD Z LLQ Z 0 RLU on the
ATP testing device. Unfortunately, this is not the current
situation for all ATP testing devices and without a vali-
dation process, most field users would be unaware of
these failure risks on the particular brand of ATP testing
device [7]. The LLQ of several ATP testing devices is
indicated in Table 1.
In addition to brand differences between ATP testing
devices there is a problem with inherent variability. Preci-
sion is the ability of the ATP testing device to repeatedly
provide the same RLU reading at the same ATP
Table 2 Suggested formula for cleanliness standard








TC1 TC1 Z TC2  2 Z TC3  4
TC2 TC2 Z TC1 O 2 Z TC3  2
TC3 TC3 Z LLQ þ 25 RLU
(may be higher for some devices)
The ATP algorithm 171concentration. With ATP testing devices, the imprecision is
high reflected by the Coefficient of variance (Cv) [18,23].
Controlled experiments have demonstrated that aCv of 0.4 is
a frequent occurrence [24]. In studies using a single sampling
point, where the Cv is above 0.4, there is a 20% chance that
any reading could be wrong by a factor of two [25].
The variability problems could be mitigated substan-
tially with the development of a unified RLU scale against
which the ATP testing devices could be calibrated. This
would allow for accuracy and improved precision.
But short of re-engineering the ATP devices, the most
practical way tomitigate this variability is through the use of
a well-considered sampling plan [26]. We have previously
trialled using the median of quadruplicate testing to remove
outlier impacts [26]. This has the immediate drawback of
additional costs in terms of both time and consumables.
In summary, we believe that the practical application of
current ATP testing devices in healthcare settings requires
standardised instructions or guidelines specifying the sam-
pling area, sampling methodology and number of samples.
We propose the following algorithm as a first attempt to
carefully and systematically address these issues.Methods
The ATP testing algorithm
The goal of this algorithm is to maximise confidence in the
practical application of ATP testing devices in the mea-
surement of ATP. This sampling algorithm can improve the
reliability from the ATP readings to more than 99% certainty
based on known probabilities. Central to the use of ATP
testing as a monitoring process is a carefully constructed
sampling plan including an appropriate array of high touch
objects and surfaces, relevant for targeted cleaning and
therefore requiring a higher standard of cleanliness moni-
toring [20].
There are four steps in this algorithm.
1. A standardised ATP swab sampling area of
2  5cm Z 10 cm2.
2. An initial two sample approach, using adjacent sampling
on the surface to be tested. Additional samples may be
required where the initial duplicate sample results are
ambiguous. On objects with small surface areas the
duplicate sampling approach will necessitate over-
lapping samples.
3. A four-tiered cleanliness rating (Table 2) based on the
known dynamic range and existing published test results
of the ATP testing devices used for sampling.
4. The final control step for cleanliness verification using a
disposable wipe, and then re-testing (single ATP swab) of
the cleaned area.
Initial ATP sampling in duplicate
If the ‘true’ ATP value for a surface was exactly equal to
the cleanliness threshold e let’s say 100 RLU e then the
random variation in the measurement device could be ex-
pected to result in about half of the individual readings
being above and half being below this true value. So, asingle measurement interpreted against the 100 RLU
threshold has a 50% probability measuring less than the
cleanliness threshold (a false negative result).
We seek to improve decision making by combining two or
more ATP measures. In the above scenario where the true
ATP is exactly equal to the threshold, there is only 25%
(50 %  50 % Z 25%) of two readings measuring below the
threshold and 12.5% chance for 3 readings in a row (6.25%
for four readings in a row). Where the true ATP values are
higher than the threshold, the probability of false negative
readings decrease rapidly.
As discussed above, our previous research has suggested
that a Cv of 0.2 is average for any set of readings. A Cv as
high as 0.4 will also occur in normal field usage. Based on
the work of Reed et al. a Cv of 0.4 suggests that any two
measures from the identical surface could differ by a factor
of 1.5 or more in nearly half of all trials and differ by a
factor of 2 or more in 1 in every 5 trials [23]. In such cases, a
reading of 50 RLU and 100 RLU could be generated from the
same surface cleanliness and still represent the same result
[24,25]. While a Cv of 0.4 was relatively infrequent, our
proposed algorithm is conservative and based on the
possible two-fold difference in RLU measures. Within the
health care environment, the emphasis should be to mini-
mise false negative readings i.e. to minimise the chance of
mislabelling a dirty surface as a clean surface.
Combining the above considerations and using the 100
RLU cleanliness threshold for convenience we can conclude:
 Two readings below 100 provide good evidence of
cleanliness (at very worst 0.25 risk of false negative
result if both readings are very close to the threshold)
 Two readings below 100, one of which is below 50 pro-
vides strong evidence of cleanliness (given the Cv of 0.4
is relatively rare, the possibility of one of the observa-
tions lying two-fold below the threshold is very small)
 Two readings below 50 providing very strong evidence of
cleanliness
 Two readings below 25 providing exceptional evidence of
cleanliness.
By the same logic, two readings above the cleanliness
threshold should be treated as insufficiently clean. The
more difficult to interpret results is one reading below and
the other above the cleanliness threshold. In such cases we
recommend a third swab with the median of the three to be
compared against the cleanliness threshold.
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The four groups are separated by the three cleanliness
thresholds, being TC1, TC2 and TC3. These are shown in
Table 1 below with the suggested RLU readings for three
tested ATP devices.
For at least two devices (Cleantrace and Hygiena)
cleanliness thresholds have been proposed. The upper
cleanliness threshold for the Hygiena device is indicated as
100 RLU [20,21]. For the Cleantrace device the first
cleanliness threshold was firstly suggested at 500 RLU [1].
More recent work revised this down to 250 RLU [10]. For the
purposes of this algorithm, and given what is now known
about the variance issues, the first threshold of 500 RLU for
the Cleantrace ATP device is accepted as appropriate for
TC1 and the revised threshold conforms to the expectations
for TC2.
It is readily acknowledged that other branded ATP
testing devices could be incorporated into our algorithm
subject to presentation of the dynamic range and estab-
lishment of the LLQ for that device.
The relationship between the three tiers of cleanliness
threshold is outlined in Table 2. Using the two-fold differ-
ence rule, the initial cleanliness threshold (TC1) will be
twice as much as the secondary threshold (TC2) and four
times the tertiary or lower cleanliness threshold (TC3). The
lowest cleanliness threshold should be set just above the
LLQ for the individual brand of ATP testing device, and 25
RLU is suggested as a guideline for the reading gap between
the LLQ and the TC3 threshold.
Two readings above TC1 are interpreted as strong evi-
dence for insufficient cleanliness. Two readings which are
below TC2 are interpreted as very strong evidence of
cleanliness and two observations below TC3 are interpreted
as very strong evidence of cleanliness.
The sampling process steps for ATP testing
The process of ATP testing (sampling) follows the protocol
summarised in Fig. 1. Firstly duplicate samples are taken
using the ATP testing device based on a standardised sam-
pling area of 10 cm2. The ATP swabs are taken on imme-
diately parallel locations on the chosen environmental
surface or medical device. Wherever possible the duplicate
sampling areas should not be overlapped. Whilst it isFigure 1 ATP testing algorithm as a flow chart uspreferable never to overlap sampling, on small surfaces
(e.g. a four pointed tap handle) this may be problematic so
overlapping of any sampling should be recorded.
From the duplicate sampling four possible outcomes are
obtained. Firstly, both ATP testing results, measured in
RLU, may be below the initial cleanliness threshold (TC1).
These results are classified as group A in the algorithm
shown in Fig. 2. Secondly, both results could be RLU read-
ings above TC1, and these results are shown as group B in
the algorithm. For both groups A & B, the median RLU result
is accepted. In either case, a cleanliness verification step is
then conducted.
The third possible outcome from the initial duplicate
testing (group C) is that the two results may indicate RLU
readings on either side of TC1. In this case a triplicate
reading is required. If one of the three readings has a value
more than ten-fold different from any other value in the
sampling group, then a fourth sample reading is also
required. Each additional ATP sample should be taken by
swabbing on the same surface and if possible the sampling
areas should not be overlapped.
For any surface sample group of readings which requires
triplicate or quadruplicate ATP samples these samples are
classified as sample group C on the algorithm. The median
value is accepted as the indicative value to group C samples.
This ATP sampling algorithm does not intend to over-
come what are sampling methodology issues. The non-
uniform distribution of ATP rich soils can be expected to
interfere with results patterns. For this reason it is impor-
tant to sample from a sufficiently large variety of surfaces
or implements to ensure that cleanliness estimates are less
likely to result in either false positive or false negative
conclusions.
After the last sample swab is taken, the surface may also
be sampled for specific microbial presence. Where envi-
ronmental sampling to be conducted, it is recommended to
use a more aggressive environmental sampling method on a
parallel surface and not overlapped with the ATP sampling
regions [27].
The cleanliness verification step
The cleanliness verification is required to test the cleanli-
ness capacity of the surface as well as to provide anothering cleanliness thresholds (see Tables 1 and 2).
Figure 2 The ATP sampling algorithm.
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verification step is undertaken immediately following the
initial testing and prior to any further use of the surface or
medical device. Thus all of the sampling is finalised quickly
and the surface or device returned to normal uses in a time
efficient manner.
The cleanliness verification step is conducted using a
disposable neutral or anionic detergent wipe. The wipe is
used as per Maillard et al. with a single wipe used on a
single surface and wiped in a single direction [28]. In
practice this is done by removing the wipe from the packet
with gloved hand, and using the first side (side 1) to wipe
generally over the device or surface being tested to thor-
oughly wet the surface. The wipe is then folded in half so
that side 1 is on the inside of the folded wipe. The wipe now
has two surfaces on side 2, being 2a and 2b. The area beingtested is then strongly wiped using the 2a side of the wipe
in a single wiping action across the surface or device.
The wipe is then turned over so that side 2b is facing
down, and this side is then also wiped strongly across the
surface in a single direction. Thus a double wiping action
ensures cleaning to the equivalence of a disinfectant
applied to the same surface [29]. Care should be taken
when wiping to keep the wiping action inside the wetted
area so that any contamination outside of the wetted area
is not introduced into the testing area.
The cleaned area is allowed to air dry for several mo-
ments. A final ATP swab test is immediately conducted once
the cleaned area is fully dry and before any subsequent
hand or other contact. The results of the cleanliness veri-
fication step, second stage ATP reading should demonstrate
a reading below the secondary cleanliness threshold (TC2).
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from the initial cleanliness threshold. Where the second
stage ATP reading is above TC2, then the cleanliness veri-
fication step should be repeated.
Our initial work on this step has indicated that with some
very unclean surfaces, the cleanliness verification step may
be required to be repeated several times to bring the
cleanliness level into compliance with TC2. This secondary
threshold is set a level outside of the two fold variance
level from the initial threshold.
Initial field trials have indicated that samples designated
as Group D represent surfaces where no statistically sig-
nificant improvement can be achieved via the cleanliness
verification step.
The full testing algorithm is outlined in Fig. 2.Discussion
This algorithm is designed to reduce the impact of inherent
variability and imprecision on any individual sampling sur-
face or medical device. The algorithm makes use of previ-
ously reported probabilities and, based on the known
variance of ATP testing devices, uses a multiple sampling
step to increase certainty over the true values obtained
when using an ATP testing device. The use of the cleanli-
ness verification step further confirms the initial reading
results by demonstrating the cleanliness value that would
be possible with a validated cleaning method.
Our work using this algorithm has indicated that a ter-
tiary threshold which is half of the secondary threshold will
be required to demonstrate a level of cleanliness which
cannot be improved upon. In this algorithm the upper
threshold acts as a true upper threshold when the key
secondary threshold is 50% of that value. Thus, any variance
within the expected range of a factor of 2 from the key
secondary threshold will fall within the nominal range of
the upper and the lower thresholds.
This simple approach is applicable to the three ATP
testing devices so far validated for dynamic range and
variability. Other ATP testing devices will require a clearly
defined LLQ before the algorithm may be used with the
cleanliness thresholds as set out in this paper.
So, for Hygiena ATP devices the key threshold is set at
50 RLU, thus rendering 100 RLU as the uppermost
threshold whilst preserving values of 25 RLU and below as
the lower cleanliness value. The LLQ has been demon-
strated at 0 RLU for the Hygiena device. For the Clean-
trace device a tiered cleanliness threshold is suggested
with the upper threshold being 500 RLU, the secondary
threshold as 250 RLU and the lower cleanliness threshold
as 125 RLU. The LLQ for the Cleantrace device is shown to
be around 100 RLU. The LLQ for the Kikkoman device is
shown to be around 90 RLU.
The testing for this algorithm was initially conducted
within a food surveillance context where cleanliness
measurements are also visually based and are in urgent
need of a more scientific approach. Work applying this
algorithm within a healthcare cleanliness context has
commenced with several Australian studies using the al-
gorithm sampling methodology as outlined. More work is
required to validate this method within healthcaresettings and with a greater variety of branded ATP testing
devices.
There are a number of limitations with this algorithm.
Firstly, the LLQ values for ATP testing devices is limited to
just three brands where data is known and published.
Secondly, field testing of the algorithm remains limited at
this time. Thirdly, the work is proposed without any support
from any of the ATP testing device manufacturers. Finally,
there remains no direct link between detectable levels of
ATP and the presence or absence of an MRO. So whilst ATP
testing can reliably detect general cellular cleanliness, the
level of ATP detected is not a direct indicator of disease or
infection risk.
Whereas the broader sampling issues such as soiling
distribution and types of soils are subject to the normal
vagaries’ of sampling methodology, and are not overcome
through this algorithm, the use of the algorithm does
improve the value of a well-designed sampling approach to
improve the overall reliability of cleanliness monitoring
within healthcare settings.
We propose this algorithm as an improvement to the
science behind cleanliness testing in healthcare settings
using ATP testing devices. This algorithm would be more
useful in the context of a standardised RLU scale, but this
is not currently available. Advances in the standard of
consumables and reduction of inherent variability in ATP
detection would enhance the usefulness of this Algorithm
and ATP testing as an infection prevention or hygiene
measurement tool. Studies using ATP testing devices have
demonstrated the advantage of speed of response for
cleanliness measurement, and this algorithm is intended
to improve reliability in addition to timeliness in
answering questions over surface or medical device
cleaning.
Conclusion
It is important that there is a reliable and quantitative
method for cleanliness monitoring in situations where vi-
sual inspection is the only existing alternative for real time
assessment and feedback on surface hygiene. This new ATP
sampling algorithm provides a superior level of certainty
with field based ATP data through the mitigation of
inherent device imprecision and variability. The sampling
algorithm requires structured field testing to confirm its
practical use in a range of different settings. The use of ATP
testing for improvement the quality monitoring of surface
cleanliness and cleaning outcomes may be improved
through the application of this new approach.
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